tirzepatide benefits vs semaglutide as Compared with for the Treatment of Obesity Switching Semaglutide to Tirzepatide |
Description
It increases insulin production, a hormone that lowers the blood sugar level while inhibiting glucagon secretion
obesity patients currently receiving prescription GLP-1 anti-obesity medication
Microdosing tirzepatide and low-dose semaglutide protocols have gained traction among users who want moderate appetite suppression without the stronger effects and side effects of full therapeutic doses
Highlights of prescribing information
